CAS 294891-81-9

BML-286

CAS: 294891-81-9

BML-286 is a WNT pathway modulator with potential anticancer activity and induces β-catenin- and TCF- dependent transcriptional activity.

Formel: C₂₂H₁₈N₂O₄

Reinheit: 98.44%

Farbe und Form: Solid

Molekulargewicht: 374.39

Ref: TM-T200419

BML-286

CAS: 294891-81-9

BML-286

Reinheit: ≥98%

Molekulargewicht: 374.39g/mol

Ref: 54-BUP00605

BML-286

Kontrolliertes Produkt

CAS: 294891-81-9

Applications A small molecule inhibitor of the PDZ domain of Dishevelled (Dvl): an essential protein in the Wnt signaling pathways. This compound reduced the levels of apoptosis in the hyaloid vessels of the eye and also suppressed the growth of prostate cancer PC-3 cells. It is a useful tool for studies dissecting the Wnt signaling pathways.
References Grandy, D. et al.: J. Biol. Chem., 284, 24 (2009);

Formel: C₂₂H₁₈N₂O₄

Farbe und Form: Neat

Molekulargewicht: 374.389

Ref: TR-B595870

BML 286

CAS: 294891-81-9

Inhibits dishevelled (Dvl)-PDZ domain interaction; affects Wnt signaling pathway

Formel: C₂₂H₁₈N₂O₄

Reinheit: Min. 95%

Molekulargewicht: 374.39 g/mol

Ref: 3D-FB18841